Claims
- 1. A process for the preparation of 3-phenylpropanal, wherein cinnamaldehyde is hydrogenated with the aid of a Pd-containing catalyst, such that 1-5 wt. % water, relative to the amount of cinnamaldehyde, is present in the reaction mixture during the reaction.
- 2. The process according to claim 1, wherein the hydrogenation is carried out in the presence of potassium acetate.
- 3. The process according to claim 1 or claim 2, wherein the hydrogenation is carried out at a temperature of between 55.degree. and 90.degree. C.
- 4. The process according to claim 1, wherein the hydrogenation is carried out at a pressure of between 4 and 8 MPa.
- 5. The process for the preparation of 3-phenylpropionic acid, wherein cinnamaldehyde is converted into 3-phenylpropanal according to claims 1, after which the 3-phenylpropanal obtained is subjected to an oxidation using a medium containing molecular oxygen.
- 6. The process according to claim 5, wherein the oxidation takes place at a pressure between 0.2 and 2 MPa.
- 7. The process according to claim 5 or claim 6, wherein the oxidation takes place at a temperature between 50.degree. and 70.degree. C.
- 8. The process according to claim 6, wherein the oxidation is carried out in the absence of a solvent.
- 9. The process according to claim 5, wherein the oxidation is carried out in the absence of a catalyst.
- 10. The process for the preparation of an HIV protease inhibitor, wherein 3-phenylpropionic acid is prepared using the process according to claims 5, 6 or 9 and thereafter is converted into said HIV protease inhibitor.
- 11. The process for preparing an intermediate reagent, wherein 3-phenylpropionic acid obtained according to claim 5 is converted to its corresponding acid chloride.
- 12. The process according to claim 5, wherein the oxidation takes place at temperatures between 50.degree. C. and 70.degree. C. in the absence of a catalyst.
- 13. The process according to claim 12, wherein the oxidation is conducted at a pressure of between 0.2 and 2 Mpa.
- 14. The process according to claim 12, wherein the hydrogenation of cinnamaldehyde occurs in the presence of potassium acetate.
- 15. The process according to claim 14, wherein the hydrogenation is conducted at a temperature of between 55.degree. C. and 90.degree. C.
- 16. The process for the preparation of the antiviral pharmaceutical, an HIV protease inhibitor, wherein 3-phenylpropionic acid made according to claims 5, 6 or 9 is used as an intermediate reagent in the synthesis.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9401708 |
Oct 1994 |
NLX |
|
Parent Case Info
This is a continuation of International Appln. No. PCT/NL95/00359 filed Oct. 17, 1995 which designated the U.S.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3520934 |
Dunkel et al. |
Jul 1970 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
2 030 031 |
Dec 1971 |
DEX |
955421 |
Jan 1964 |
GBX |